CMS is supporting the incorporation of FDA's unique device identifiers in insurance claims forms, a boon to medical researchers who would receive a bounty of data about medical device safety and effectiveness.
With less than 4 months for the implementation of the FDA’s third phase of the UDI system, companies with Class II devices need to ensure steps are taken to establish UDI for their products.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.